Amubarvimab (BRII-196) is a human IgG1 monoclonal antibody designed to target distinct, non-competing epitopes on the receptor-binding domain (RBD) of the SARS-CoV-2 spike protein. It exhibits a binding affinity with a dissociation constant (K_D) of 5.88 nM, demonstrating potent neutralization capabilities against various SARS-CoV-2 variants. This specificity and efficacy make Amubarvimab a valuable tool for research into the mechanisms of viral entry and immune evasion.
Amubarvimab (BRII-196) is a human IgG1 monoclonal antibody designed to target distinct, non-competing epitopes on the receptor-binding domain (RBD) of the SARS-CoV-2 spike protein. It exhibits a binding affinity with a dissociation constant (K_D) of 5.88 nM, demonstrating potent neutralization capabilities against various SARS-CoV-2 variants. This specificity and efficacy make Amubarvimab a valuable tool for research into the mechanisms of viral entry and immune evasion.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula: